Tarsus Pharmaceuticals Inc
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.06 | -1.23 | -1.07 | -0.38 | -0.23 | -0.58 | -0.52 | -0.69 | 0.43 | 0.45 | -0.57 | 1.54 | 1.84 | |
| 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.05 | |
| 0.17 | 0.17 | 0.16 | 0.20 | 0.19 | 0.19 | 0.18 | 0.19 | 0.29 | 0.33 | 0.28 | 0.31 | 1.19 | |
| 0.05 | -0.09 | -0.24 | 0.27 | -0.04 | -0.15 | -0.05 | -0.39 | 0.45 | 0.32 | -0.69 | 0.81 | 0.89 | |
| 0.14 | 0.13 | 0.00 | 0.03 | 0.01 | 0.13 | 0.01 | 0.02 | 0.04 | 0.15 | 0.14 | 0.09 | 0.42 | |
| 1.55 | 0.56 | -2.90 | -1.07 | 0.08 | -1.54 | -0.89 | -1.22 | -0.11 | 1.15 | -1.36 | 0.87 | 0.55 | |
| – | – | – | -0.18 | 0.17 | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.00 | 0.00 | – | – | 0.00 | 0.00 | – | – | – | |
| 3.43 | 0.62 | 3.08 | 1.12 | 0.02 | 0.08 | 3.47 | 0.05 | 0.06 | 0.05 | 0.03 | 0.08 | 0.22 | |
| 3.92 | -0.05 | -0.89 | -0.33 | -0.13 | -2.04 | 2.06 | -1.87 | 0.38 | 1.66 | -1.91 | 2.49 | 2.61 | |
| -1.20 | -1.23 | -1.08 | -0.41 | -0.23 | -0.71 | -0.54 | -0.72 | 0.38 | 0.30 | -0.71 | 1.44 | 1.42 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.